Pregabalin Sandoz GmbH

Riik: Euroopa Liit

keel: inglise

Allikas: EMA (European Medicines Agency)

Osta kohe

Infovoldik Infovoldik (PIL)
12-10-2023
Toote omadused Toote omadused (SPC)
12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
12-10-2023

Toimeaine:

pregabalin

Saadav alates:

Sandoz GmbH

ATC kood:

N03AX16

INN (Rahvusvaheline Nimetus):

pregabalin

Terapeutiline rühm:

Antiepileptics,

Terapeutiline ala:

Anxiety Disorders; Epilepsy

Näidustused:

EpilepsyPregabalin Sandoz GmbH is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Sandoz GmbH is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Toote kokkuvõte:

Revision: 16

Volitamisolek:

Withdrawn

Loa andmise kuupäev:

2015-06-19

Infovoldik

                                70
B. PACKAGE LEAFLET
Medicinal product no longer authorised
71
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN SANDOZ GMBH 25 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 50 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 75 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 100 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 150 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 200 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 225 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Pregabalin Sandoz GmbH is and what it is used for
2. What you need to know before you take Pregabalin Sandoz GmbH
3. How to take Pregabalin Sandoz GmbH
4. Possible side effects
5. How to store Pregabalin Sandoz GmbH
6. Contents of the pack and other information
1.
WHAT PREGABALIN SANDOZ GMBH IS AND WHAT IT IS USED FOR
Pregabalin Sandoz GmbH belongs to a group of medicines used to treat
epilepsy and Generalised
Anxiety Disorder (GAD) in adults.
EPILEPSY:
Pregabalin Sandoz GmbH is used to treat a certain form of epilepsy
(partial seizures with or
without secondary generalisation) in adults. Your doctor will
prescribe Pregabalin Sandoz GmbH for
you to help treat your epilepsy when your current treatment is not
controlling your condition. You
should take Pregabalin Sandoz GmbH in addition to your current
treatment. Pregabalin Sandoz GmbH
is not intended to be used alone, but should always be used in
combination with other anti-epileptic
treatment.
GENERALISED ANXIETY DISORDER:
Pregabalin Sandoz
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
Medicinal product no longer authorised
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Sandoz GmbH 25 mg hard capsules
Pregabalin Sandoz GmbH 50 mg hard capsules
Pregabalin Sandoz GmbH 75 mg hard capsules
Pregabalin Sandoz GmbH 100 mg hard capsules
Pregabalin Sandoz GmbH 150 mg hard capsules
Pregabalin Sandoz GmbH 200 mg hard capsules
Pregabalin Sandoz GmbH 225 mg hard capsules
Pregabalin Sandoz GmbH 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Sandoz GmbH 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Sandoz GmbH 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Sandoz GmbH 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Pregabalin Sandoz GmbH 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Sandoz GmbH 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Pregabalin Sandoz GmbH 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Pregabalin Sandoz GmbH 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Sandoz GmbH 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsule.
Pregabalin Sandoz GmbH 25 mg hard capsules
Pale yellow-brown opaque cap and body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
Pregabalin Sandoz GmbH 50 mg hard capsules
Light yellow opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm),
filled with white to nearly
white coloured powder.
Pregabalin Sandoz GmbH 75 mg hard capsules
Red opaque cap and white opaque body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
Medicinal product no longer authorised
3
Pregabalin Sandoz GmbH 100 mg hard capsules
Red opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm), filled
with white to nearly white
coloured powder.
Pregabalin Sandoz
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik bulgaaria 12-10-2023
Toote omadused Toote omadused bulgaaria 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande bulgaaria 12-10-2023
Infovoldik Infovoldik hispaania 12-10-2023
Toote omadused Toote omadused hispaania 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande hispaania 12-10-2023
Infovoldik Infovoldik tšehhi 12-10-2023
Toote omadused Toote omadused tšehhi 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande tšehhi 12-10-2023
Infovoldik Infovoldik taani 12-10-2023
Toote omadused Toote omadused taani 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande taani 12-10-2023
Infovoldik Infovoldik saksa 12-10-2023
Toote omadused Toote omadused saksa 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande saksa 12-10-2023
Infovoldik Infovoldik eesti 12-10-2023
Toote omadused Toote omadused eesti 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande eesti 12-10-2023
Infovoldik Infovoldik kreeka 12-10-2023
Toote omadused Toote omadused kreeka 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande kreeka 12-10-2023
Infovoldik Infovoldik prantsuse 12-10-2023
Toote omadused Toote omadused prantsuse 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande prantsuse 12-10-2023
Infovoldik Infovoldik itaalia 12-10-2023
Toote omadused Toote omadused itaalia 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande itaalia 12-10-2023
Infovoldik Infovoldik läti 12-10-2023
Toote omadused Toote omadused läti 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande läti 12-10-2023
Infovoldik Infovoldik leedu 12-10-2023
Toote omadused Toote omadused leedu 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande leedu 12-10-2023
Infovoldik Infovoldik ungari 12-10-2023
Toote omadused Toote omadused ungari 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande ungari 12-10-2023
Infovoldik Infovoldik malta 12-10-2023
Toote omadused Toote omadused malta 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande malta 12-10-2023
Infovoldik Infovoldik hollandi 12-10-2023
Toote omadused Toote omadused hollandi 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande hollandi 12-10-2023
Infovoldik Infovoldik poola 12-10-2023
Toote omadused Toote omadused poola 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande poola 12-10-2023
Infovoldik Infovoldik portugali 12-10-2023
Toote omadused Toote omadused portugali 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande portugali 12-10-2023
Infovoldik Infovoldik rumeenia 12-10-2023
Toote omadused Toote omadused rumeenia 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande rumeenia 12-10-2023
Infovoldik Infovoldik slovaki 12-10-2023
Toote omadused Toote omadused slovaki 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande slovaki 12-10-2023
Infovoldik Infovoldik sloveeni 12-10-2023
Toote omadused Toote omadused sloveeni 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande sloveeni 12-10-2023
Infovoldik Infovoldik soome 12-10-2023
Toote omadused Toote omadused soome 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande soome 12-10-2023
Infovoldik Infovoldik rootsi 12-10-2023
Toote omadused Toote omadused rootsi 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande rootsi 12-10-2023
Infovoldik Infovoldik norra 12-10-2023
Toote omadused Toote omadused norra 12-10-2023
Infovoldik Infovoldik islandi 12-10-2023
Toote omadused Toote omadused islandi 12-10-2023
Infovoldik Infovoldik horvaadi 12-10-2023
Toote omadused Toote omadused horvaadi 12-10-2023
Avaliku hindamisaruande Avaliku hindamisaruande horvaadi 12-10-2023

Otsige selle tootega seotud teateid